STOCK TITAN

Blackstone entities report 24.4% ownership stake in Medline Inc. (MDLN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Medline Inc. received a Schedule 13G showing that entities affiliated with Blackstone report beneficial ownership of 215,303,036 shares of Medline Class A common stock, or 24.4% of the class. This percentage is based on 811,418,179 Class A shares outstanding as of December 18, 2025.

The filing explains that Mozart Aggregator II LP directly holds 142,918,680 Class A shares, while BCP Mozart Aggregator L.P. directly holds 11,724 Class A shares and 72,372,632 Common Units of Medline Holdings, LP paired with an equal number of non‑economic Class B shares. These Common Units can be exchanged on a one‑for‑one basis for Class A shares without expiration, with the corresponding Class B shares cancelled on exchange.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Mozart Aggregator II LP
Signature:/s/ Robert Brooks
Name/Title:By: Blackstone Management Associates VIII L.L.C., its GP, By: BMA VIII L.L.C., its GP, By: Robert Brooks, Authorized Signatory
Date:02/13/2026
BCP Mozart Aggregator L.P.
Signature:/s/ Robert Brooks
Name/Title:By: BCP 8 Holdings Mozart Manager L.L.C., its general partner, By: BMA VIII L.L.C., its managing member, By: Robert Brooks, Authorized Signatory
Date:02/13/2026
Blackstone Management Associates VIII L.L.C.
Signature:/s/ Christopher Striano
Name/Title:By: BMA VIII L.L.C., its general partner, By: Christopher Striano, Senior Managing Director and Chief Operating Officer of Global Finance
Date:02/13/2026
BCP 8 Holdings Mozart Manager L.L.C.
Signature:/s/ Christopher Striano
Name/Title:By: BMA VIII L.L.C., its managing member, By: Christopher Striano, Senior Managing Director and Chief Operating Officer of Global Finance
Date:02/13/2026
BMA VIII L.L.C.
Signature:/s/ Christopher Striano
Name/Title:Christopher Striano, Senior Managing Director and Chief Operating Officer of Global Finance
Date:02/13/2026
Blackstone Holdings II L.P.
Signature:/s/ Victoria Portnoy
Name/Title:By: Blackstone Holdings I/II GP L.L.C., its general partner, By: Victoria Portnoy, Managing Director - Assistant Secretary
Date:02/13/2026
Blackstone Holdings I/II GP L.L.C.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:02/13/2026
Blackstone Inc.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:02/13/2026
Blackstone Group Management L.L.C.
Signature:/s/ Victoria Portnoy
Name/Title:Victoria Portnoy, Managing Director - Assistant Secretary
Date:02/13/2026
Stephen A. Schwarzman
Signature:/s/ Stephen A. Schwarzman
Name/Title:Stephen A. Schwarzman
Date:02/13/2026
Exhibit Information

EXHIBIT LIST Exhibit 99.1 Joint Filing Agreement, by and among the Reporting Persons, dated as of February 13, 2026.

FAQ

What percentage of Medline Inc. (MDLN) does the Blackstone group report owning?

The Blackstone-affiliated reporting persons may be deemed to beneficially own 24.4% of Medline’s Class A common stock. This is based on 215,303,036 shares attributed to them and 811,418,179 Class A shares outstanding as of December 18, 2025.

How many Medline Inc. (MDLN) Class A shares does Mozart Aggregator II LP hold?

Mozart Aggregator II LP directly holds 142,918,680 shares of Medline Class A common stock. This position contributes to the broader Blackstone reporting group’s aggregate 215,303,036 shares that may be deemed beneficially owned under Schedule 13G.

What Medline Inc. (MDLN) securities does BCP Mozart Aggregator L.P. hold?

BCP Mozart Aggregator L.P. holds 11,724 Medline Class A shares and 72,372,632 Common Units of Medline Holdings, LP, plus an equal number of non‑economic Class B shares. Each Common Unit is exchangeable one‑for‑one into Class A shares, with matching Class B shares cancelled.

How is the 24.4% Medline (MDLN) ownership percentage calculated in the Schedule 13G?

The 24.4% figure is calculated under SEC Rule 13d‑3 using 811,418,179 Medline Class A shares outstanding as of December 18, 2025, and assuming conversion of all Common Units beneficially owned by each reporting person into Class A shares on a one‑for‑one basis.

Who are the main reporting persons in the Medline Inc. (MDLN) Schedule 13G?

The filing lists multiple Blackstone-affiliated entities, including Mozart Aggregator II LP, BCP Mozart Aggregator L.P., Blackstone Management Associates VIII L.P., BMA VIII L.L.C., Blackstone Holdings II L.P., Blackstone Inc., and others, along with Stephen A. Schwarzman, as reporting persons under Section 13(d).

What are Medline Inc. (MDLN) Class B shares mentioned in the Schedule 13G?

Medline’s Class B common stock has no economic value and carries one vote per share. One Class B share is issued for each Common Unit held, and when Common Units are exchanged for Class A shares, an equivalent number of corresponding Class B shares is automatically cancelled.
MEDLINE INC

NASDAQ:MDLN

MDLN Rankings

MDLN Latest News

MDLN Latest SEC Filings

MDLN Stock Data

37.07B
216.03M